Clinical Trial: A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Adult Participants

U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07535970) titled 'A Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10506 in Healthy Chinese Adult Participants' on March 20.

Brief Summary: A single-center, open-label, fixed-sequence, self-controlled phase I clinical trial aimed at evaluating the effect of itraconazole capsules(CYP3A inhibitor) on the pharmacokinetics of HS-10506 tablets in healthy participants.

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Healthy Participants

Intervention: DRUG: HS-10506, Itraconazole

HS-10506: Administered under fasting conditions in the morning. Itraconazole: Itraconazole capsules (0.2 g) are taken o...